Evidence map›Paper›PMID 30847340›Full record

ArticleFrontiers in chemistry2019

Cocrystal Formation of Betulinic Acid and Ascorbic Acid: Synthesis, Physico-Chemical Assessment, Antioxidant, and Antiproliferative Activity.

Mirela Nicolov, Roxana M Ghiulai, Mirela Voicu, Marius Mioc, Adina Octavia Duse, Roxana Roman, Rita Ambrus, Istvan Zupko, Elena Alina Moaca, Dorina E Coricovac and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Mirela NicolovFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Roxana M GhiulaiFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Mirela VoicuFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Marius MiocFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Adina Octavia DuseFaculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Roxana RomanFaculty of Physics, West University of Timisoara, Timisoara, Romania.
Rita AmbrusInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary.
Istvan ZupkoDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Szeged, Hungary.
Elena Alina MoacaFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Dorina E CoricovacFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Claudia FarcasFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Roxana Marcela RacoviceanuFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Corina DanciuFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Cristina-Adriana DeheleanFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Codruta SoicaFaculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · ROUniversity of Szeged · HUWest University of Timişoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Betulinic acid (BA) was demonstrated to be a very promising anticancer agent against various tumor cell lines such as breast, colon, lung, and brain. Despite its strong cytotoxic effect, betulinic acid exhibits low water solubility, feature that is reflected in its poor bioavailability. To overcome these drawbacks, numerous strategies were conducted to improve its physicochemical and pharmacokinetic profile, among which cocrystalization emerged as a promising approach. Thus, our work consisted in obtaining slowly grown cocrystals of BA and ascorbic acid (BA+VitC) in isopropyl alcohol obtained in a hydrothermal experiment. The newly formed cocrystals were characterized by physico-chemical methods such asSEM, DSC, XRPD, and FT-IR spectroscopy demonstrating BA+VitC cocrystal formation while their antioxidant activity revealed an additive antioxidant effect. To investigate the biological effect, BA+VitC cocrystals were tested on HaCat (immortalized human keratinocytes), B164A5 and B16F0 (murine melanoma), MCF7 and MDA-MB-231 (human breast cancer), and HeLa (cervical cancer) cell lines. Results of BA upon the tested tumor cell lines, after co-crystallization with vitamin C, indicated a superior cytotoxic effect with the preservation of a good selectivity index assumably due to an improved BA water solubility and consequently an optimized bioavailability.

Indexed as

antioxidant activityantiproliferative activitybetulinic acidcocrystalvitamin C

Identifiers

PMID30847340
PMCPMC6393380
OpenAlexW2914901374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.